Acute cognitive effects of single-dose intravenous ketamine in major depressive and posttraumatic stress disorder

Intravenous (IV) subanesthetic doses of ketamine have been shown to reduce psychiatric distress in both major depressive (MDD) and posttraumatic stress disorder (PTSD). However, the effect of ketamine on cognitive function in these disorders is not well understood. To address this gap, we examined t...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Margaret T., DellaGiogia, Nicole, Maruff, Paul, Pietrzak, Robert H., Esterlis, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032778/
https://www.ncbi.nlm.nih.gov/pubmed/33833217
http://dx.doi.org/10.1038/s41398-021-01327-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032778/
https://www.ncbi.nlm.nih.gov/pubmed/33833217
http://dx.doi.org/10.1038/s41398-021-01327-5

Ejemplares similares